首页>
外国专利>
SOLUBLE CD33 FOR TREATING MYELODYSPLASTIC SYNDROMES (MDS)
SOLUBLE CD33 FOR TREATING MYELODYSPLASTIC SYNDROMES (MDS)
展开▼
机译:可溶性CD33用于治疗骨髓增生异常综合征(MDS)
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed are compositions and methods for treating disease or condition caused or exacerbated by S100A9 activity, such as myelodysplastic syndromes (MDS) using a composition comprising an effective amount of a CD33/S100A9 inhibitor.
展开▼